Chatterji
Anjan Chatterji, New York, NY US
Patent application number | Description | Published |
---|---|---|
20140031312 | COMPOSITIONS AND FORMULATIONS OF GLUCOSAMINE FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION - Disclosed are compositions and formulations comprising glucosamine or a pharmaceutically acceptable salt thereof for use in the treatment of joint conditions and adapted for use in a bath or soak or bath beads, powders, salts, and oils, kits, and methods of treatment using the same. Also disclosed are lozenges, suppositories, patches, and topical creams comprising glucosamine or a pharmaceutically acceptable salt thereof for use in the treatment of joint conditions and methods of treatment using the same. In some embodiments the joint conditions include osteoarthritis. | 01-30-2014 |
20150283156 | COMPOSITIONS AND FORMULATIONS OF GLUCOSAMINE FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION - Disclosed are compositions and formulations comprising glucosamine or a pharmaceutically acceptable salt thereof for use in the treatment of joint conditions and adapted for use in a bath or soak or bath beads, powders, salts, and oils, kits, and methods of treatment using the same. Also disclosed are lozenges, suppositories, patches, and topical creams comprising glucosamine or a pharmaceutically acceptable salt thereof for use in the treatment of joint conditions and methods of treatment using the same. In some embodiments the joint conditions include osteoarthritis. | 10-08-2015 |
Arun K. Chatterji, Neenah, WI US
Patent application number | Description | Published |
---|---|---|
20090053332 | Compositions for diabetes treatment and prophylaxis - Gurmarin containing compositions are useful for modulation of glucose metabolism and the treatment of diabetes. Glucose metabolism in a human patient is regulated by isolated gurmarin-containing dosage forms that optionally contain a non-metabolizable polysaccharide such as the exudate of | 02-26-2009 |
20100297267 | Compositions for diabetes treatment and prophylaxis - Gurmarin containing compositions are useful for modulation of glucose metabolism and the treatment of diabetes. Glucose metabolism in a human patient is regulated by isolated gurmarin-containing dosage forms that optionally contain a non-metabolizable polysaccharide such as the exudate of | 11-25-2010 |
20130136814 | PREPARATION FOR WEIGHT LOSS MANAGEMENT - extracts together with extracts of one or more of | 05-30-2013 |
Ashish Chatterji, East Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20080293787 | PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions. | 11-27-2008 |
20100184716 | PHARMACEUTICAL COMPOSITIONS WITH SUPERIOR PRODUCT PERFORMANCE AND PATIENT COMPLIANCE - The present invention provides novel formulations of isobutyric acid (2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-fluoro-2-isobutyryloxymethyl-4-methyl-tetrahydro-furan-3-yl ester) and hydroxypropylcellulose that provide high bulk density, low particle size better suited for improved compression and flow, good compression, and fast dissolution profiles. | 07-22-2010 |
20120039999 | PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS - Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a pH-independent in vitro release profile with NMT 70% in one hour, NMT 85% in 4 hour, and NLT 80% in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment-Resistant Depression (TRD) and Fragile X Syndrome. | 02-16-2012 |
20120040008 | PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS - Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a pH-independent in vitro release profile with NMT 70% in one hour, NMT 85% in 4 hour, and NLT 80% in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment-Resistant Depression (TRD) and Fragile X Syndrome. | 02-16-2012 |
20120129898 | PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions. | 05-24-2012 |
20120213827 | PROCESS FOR CONTROLLED CRYSTALLIZATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT FROM SUPERCOOLED LIQUID STATE BY HOT MELT EXTRUSION - A process for controlling the crystallization of certain hydrophobic active pharmaceutical ingredients (APIs) from a supercooled liquid state by hot-melt extrusion processing is described. Also described is a pharmaceutical composition comprising a solid crystalline dispersion of a cholesterol ester transfer protein inhibitor in a hydrophilic excipient matrix. In the process of the present invention, the API is fed to an extrusion system in a crystalline state contemporaneously with carrier excipients where it is first converted to a non-crystalline state by the application of heat and then subsequently recrystallized in-situ by the removal of heat and application of shear. Recrystallization of the API is controlled by carrier formulation design and the hot-melt extrusion process parameters; i.e. barrel temperature profile, feed rate, etc. | 08-23-2012 |
20140128431 | PHARMACEUTICAL COMPOSITION WITH IMPROVED BIOAVAILABILITY, SAFETY AND TOLERABILITY - The invention relates to solid dispersions of poorly soluble compounds formed by coprecipitation, resulting in improved bioavailability, safety and tolerability. The invention also relates to Purified Eudragit L100-55 used to prepare such solid dispersions. | 05-08-2014 |
20150140087 | Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists - Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a pH-independent in vitro release profile with NMT 70% in one hour, NMT 85% in 4 hour, and NLT 80% in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment-Resistant Depression (TRD) and Fragile X Syndrome. | 05-21-2015 |
20150209294 | PHARMACEUTICAL COMPOSITION AND PROCESS - There is provided a formulation comprising N-(2-chloro-6-methylbenzoyl)-4-[(2,6-dichlorobenzoyl)amino]-L-phenylalanine-2(diethylamino)ethyl ester and poloxamer 188 which is manufactured by a hot melt process. | 07-30-2015 |
Ashish Chatterji, New Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20110028524 | PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions. | 02-03-2011 |
20110245305 | PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions. | 10-06-2011 |
Bijon Chatterji, Hannover DE
Patent application number | Description | Published |
---|---|---|
20110082089 | BIOMARKERS FOR MONITORING OR PREDICTING THE TREATMENT OF CANCER - We provide for the diagnosis, prognosis and/or treatment monitoring of lung cancer or bronchial dysplasia, and the use thereof for predicting and monitoring therapeutic intervention in dysplasia or cancer patients. According to the invention at least one biomarker selected from the group consisting of APOE, APOC3, A1AT6, A2MG, PROP, TTHY, A1AG8, APOA1, APOH, GPX3, MUP8, RETBP, SAMP, VTDB, S6A11, EGFR, ApoA4, ApoM, a-raf, fetuin B, GSN, PLG, VPS28, and particular peptide sequences derived thereof, is used in the diagnosis, prognosis and/or treatment monitoring of cancer or dysplasia, in particular of lung cancer or the level of at least one of said biomarkers is measured in a body fluid sample, in particular in a blood serum sample, of a patient suffering from or being susceptible to cancer or dysplasia. | 04-07-2011 |
Bikram Chatterji, Brooklyn, NY US
Gautam Chatterji, Schenectady, NY US
Patent application number | Description | Published |
---|---|---|
20140205048 | Systems and Methods for Providing Override Control for a Feedwater Pump Recirculation Valve - Systems and methods for providing override control for a feedwater pump recirculation valve are provided. According to one embodiment, a system may include a controller and a processor communicatively coupled to the controller. The processor may be configured to receive one or more measurements associated with pump motor power driving feedwater pump flow. The feedwater pump recirculation valve may be configured to maintain a predetermined minimum recirculation flow through the feedwater pump by regulating recirculation pump flow through a recirculation line. The processor may be also configured to calculate, based at least in part on the one or more measurements, the recirculation pump flow, and compare the recirculation pump flow to the predetermined minimum recirculation flow. Based at least in part on the comparing, the processor may selectively provide an override control signal to the feedwater pump recirculation valve to selectively modify the recirculation pump flow. | 07-24-2014 |
Monalisa Chatterji, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20150025087 | AZAINDOLE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING THE SAME - The invention provides compounds of formula (I) and methods of treating a | 01-22-2015 |
Monalisa Chatterji, Karnataka IN
Patent application number | Description | Published |
---|---|---|
20110002939 | MONOCLONAL ANTIBODY AND A METHOD THEREOF - The present invention relates to a humanized IgG1 isotype anti-CD6 antibody (T1h) that binds to the Scavenger receptor cysteine-rich (SRCR) domain 1(D1) of CD6 present on the surface of thymic epithelial cells, monocytes, activated T cells and a variety of other cells types. | 01-06-2011 |
20140031529 | MONOCLONAL ANTIBODY AND A METHOD THEREOF - The present invention relates to a humanized IgG1 isotype anti-CD6 antibody (T1h) that binds to the Scavenger receptor cysteine-rich (SRCR) domain 1 (D1) of CD6 present on the surface of thymic epithelial cells, monocytes, activated T cells and a variety of other cells types. | 01-30-2014 |
Siddhartha Chatterji, New Delhi, IN US
Patent application number | Description | Published |
---|---|---|
20120046979 | USING COMMERCIAL SHARE OF WALLET TO RATE BUSINESS PROSPECTS - Commercial size of spending wallet (“CSoSW”) is the total business spend of a business including cash but excluding bartered items. Commercial share of wallet (“CSoW”) is the portion of the spending wallet that is captured by a particular financial company. A modeling approach utilizes various data sources to provide outputs that describe a company's spend capacity. Research analysts can use CSoW/CSoSW to provide a comprehensive and robust indication of the business prospects of a rated company. | 02-23-2012 |
Siddhartha Chatterji, New Delhi IN
Patent application number | Description | Published |
---|---|---|
20120185297 | Using Commercial Share of Wallet to Rate Business Prospects - Commercial size of spending wallet (“CSoSW”) is the total business spend of a business including cash but excluding bartered items. Commercial share of wallet (“CSoW”) is the portion of the spending wallet that is captured by a particular financial company. A modeling approach utilizes various data sources to provide outputs that describe a company's spend capacity. Research analysts can use CSoW/CSoSW to provide a comprehensive and robust indication of the business prospects of a rated company. | 07-19-2012 |
20130197969 | USING COMMERCIAL SHARE OF WALLET TO RATE BUSINESS PROSPECTS - Commercial size of spending wallet (“CSoSW”) is the total business spend of a business including cash but excluding bartered items. Commercial share of wallet (“CSoW”) is the portion of the spending wallet that is captured by a particular financial company. A modeling approach utilizes various data sources to provide outputs that describe a company's spend capacity. Research analysts can use CSoW/CSoSW to provide a comprehensive and robust indication of the business prospects of a rated company. | 08-01-2013 |
20140316852 | USING COMMERCIAL SHARE OF WALLET TO RATE BUSINESS PROSPECTS - Commercial size of spending wallet (“CSoSW”) is the total business spend of a business including cash but excluding bartered items. Commercial share of wallet (“CSoW”) is the portion of the spending wallet that is captured by a particular financial company. A modeling approach utilizes various data sources to provide outputs that describe a company's spend capacity. Research analysts can use CSoW/CSoSW to provide a comprehensive and robust indication of the business prospects of a rated company. | 10-23-2014 |
Sourav Chatterji, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20120095862 | COMPUTER SYSTEM AND METHOD FOR ANALYZING DATA SETS AND GENERATING PERSONALIZED RECOMMENDATIONS - Embodiments of the invention relate to a computer-implemented method and system for generating personalized recommendations for a target user based at least on stored data about the target user. The method comprises obtaining, at the server computer, data from a plurality of data sources, including entity data associated with a plurality of entities, stored in an entity database, or personal data associated with a plurality of users, stored in a user database. The personalized recommendations system then merges the entity data or personal data and maps the entity or personal data to a corresponding entity or target user, respectively. The entity or personal data is differentiated, a relevance is determined, a weight is assigned to the data and corresponding source to canonicalize the data, the respective databases are updated with the corresponding data, and then a set of personalized recommendations to the target user is generated using the updated databases. | 04-19-2012 |
20130024449 | METHOD AND APPARATUS FOR ALLOWING USERS TO AUGMENT SEARCHES - Embodiment of the invention relate to a computer-implemented method for providing augmented searches for entities to a user, the method comprising obtaining, at a server computer operated by an entity search system, user data related to a user, and obtaining entity data related to a plurality of entities. Then, the entity search system receives a query for a search for relevant entities from the user. The method then further comprises searching for a set of relevant entities based on the query, entity data, and user data, determining a set of criteria for an initial order of relevance, and determining an order of relevance of the set of relevant entities based on the set of criteria. The set of relevant entities or order of relevance may be augmented by obtaining feedback data from the user, thereby providing an augmented search for relevant entities to the user. | 01-24-2013 |
20130024456 | METHOD AND APPARATUS FOR CATEGORY BASED NAVIGATION - Embodiments of the invention relate to a category based navigation system obtaining user data related to a plurality of users relevant to the primary user. The method further comprises obtaining entity data associated with an entity in a plurality of entities. The category based navigation system then determines one or more entities relevant to the primary user, and determines an initial order of relevance of a set of relevant entities. The method further comprises categorizing and displaying the set of relevant entities with an initial categorization on a user device to the primary user. The category based navigation system may then obtain, via the user device, user feedback, adjust the initial categorization and initial order of relevance based on the user feedback; and display the adjusted categorization and adjusted order of relevance of the set of relevant entities to the primary user on the user device. | 01-24-2013 |
20130024465 | METHOD AND APPARATUS FOR QUICKLY EVALUATING ENTITIES - Embodiments of the invention relate to methods and systems for evaluating entities for a target user, the method comprising obtaining, at a server computer, entity data from a plurality of data sources. The entity data is then stored in an entity database. The method further comprises merging the entity data from the plurality of data sources, mapping the entity data to a corresponding entity, and differentiating the entity. Then a relevance is determined associated with the entity data and data source. The method further comprises generating a set of entity evaluations to the target user using the relevance, determining a set of one or more entities relevant to the primary user based on the entity data, user data, and the relevance, with an initial order of relevance, and displaying, on a user device, the set of relevant entities to the target user in the order of relevance. | 01-24-2013 |
20150332314 | SELECTING ORGANIC CONTENT AND ADVERTISEMENTS FOR PRESENTATION TO SOCIAL NETWORKING SYSTEM USERS BASED ON USER ENGAGEMENT - A social networking system dynamically adjusts a number of advertisements presented to a user along with organic content items by modifying a ranking including organic content items and advertisements. Partial engagement scores are generated for organic content items based on an expected amount of user interaction with each organic content item, and scores are generated for advertisements based on expected user interaction and bid amounts associated with each organic content item. An engagement score measuring the user's estimated interaction with a content feed including organic content items without advertisements and an additional engagement score measuring the user's estimated interaction with a content feed including organic content items and advertisements are determined from the partial engagement scores and the scores. A difference between the additional engagement score and the engagement score modifies a conversion factor used to combine expected user interaction and bid amounts to generate advertisement scores. | 11-19-2015 |
Varun Chatterji, Singapore SG
Patent application number | Description | Published |
---|---|---|
20110225635 | NON-OBTRUSIVE SECURITY SYSTEM FOR DEVICES - A security system is provided including providing a device including: storing a security rule for operation of the device when an event occurs; and implementing the security rule upon the occurrence of the event to allow non-obtrusive user access to the device. | 09-15-2011 |
Vishwajeet Chatterji, Redondo Beach, CA US
Patent application number | Description | Published |
---|---|---|
20110028093 | Bluetooth Proximity Detection System and Method of Interacting With One or More Bluetooth Devices - Some embodiments teach an apparatus for determining a proximity of one or more first Bluetooth devices. The apparatus can include: (a) at least one Bluetooth base station with (1) a Bluetooth transmitter configured to transmit one or more service discovery requests to the one or more first Bluetooth devices; and (2) a Bluetooth receiver configured to receive one or more responses from the one or more first Bluetooth devices to the one or more service discovery requests; and (b) a computational module configured to run on one or more processors and further configured to determine one or more approximate distances between the at least one Bluetooth base station and the one or more first Bluetooth devices based on the one or more responses from the one or more first Bluetooth devices. Other embodiments are disclosed. | 02-03-2011 |